Ronald M MD Kurtz, the Chief Medical Officer of $RXST, sold 5,100 shares of the company on 09-02-2026 for an estimated $35,496. We received data on the trade from a recent SEC filing. This was a sale of approximately 6.6% of their shares of this class of stock. Following this trade, they now own 71,775 shares of this class of $RXST stock.
$RXST Insider Trading Activity
$RXST insiders have traded $RXST stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $RXST stock by insiders over the last 6 months:
- MARK WILTERDING (Chief Financial Officer) sold 7,765 shares for an estimated $54,044
- RONALD M MD KURTZ (Chief Medical Officer) sold 5,100 shares for an estimated $35,496
- ERIC WEINBERG (See remarks) sold 2,041 shares for an estimated $14,205
- ILYA GOLDSHLEGER (Chief Operating Officer) sold 2,041 shares for an estimated $14,205
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$RXST Hedge Fund Activity
We have seen 97 institutional investors add shares of $RXST stock to their portfolio, and 95 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 2,603,316 shares (+81.7%) to their portfolio in Q2 2026, for an estimated $12,547,983
- ARTISAN PARTNERS LIMITED PARTNERSHIP removed 2,058,684 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $9,922,856
- MARSHALL WACE, LLP added 983,191 shares (+7726.5%) to their portfolio in Q2 2026, for an estimated $4,738,980
- MILLENNIUM MANAGEMENT LLC added 970,828 shares (+47.1%) to their portfolio in Q2 2026, for an estimated $4,679,390
- DEFILADE CAPITAL MANAGEMENT, L.P. removed 913,090 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $5,624,634
- AQR CAPITAL MANAGEMENT LLC added 897,697 shares (+141.1%) to their portfolio in Q2 2026, for an estimated $4,326,899
- UBS GROUP AG added 776,610 shares (+324.3%) to their portfolio in Q2 2026, for an estimated $3,743,260
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$RXST Revenue
$RXST had revenues of $33.7M in Q2 2026. This is an increase of 0.31% from the same period in the prior year.
You can track RXST financials on Quiver Quantitative's RXST stock page.
You can access data on RXST stock through the Quiver Quantitative API.
$RXST Price Targets
Multiple analysts have issued price targets for $RXST recently. We have seen 4 analysts offer price targets for $RXST in the last 6 months, with a median target of $9.0.
Here are some recent targets:
- David Saxon from Needham set a target price of $11.0 on 07/07/2026
- Craig Bijou from B of A Securities set a target price of $6.5 on 07/07/2026
- Larry Biegelsen from Wells Fargo set a target price of $9.0 on 05/07/2026
- Tom Stephan from Stifel set a target price of $9.0 on 03/09/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
